Discovery Of Chemical Signature For “Fast” Form Of Parkinson’s Could Lead To Earlier Detection, More Effective Disease Management, University of California, Los Angeles (UCLA) Study

free biotech news

Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

The physical decline experienced by Parkinson’s disease patients eventually leads to disability and a lower quality of life. Depending on the individual, the disorder can progress rapidly or slowly. Scientists at UCLA and colleagues have now, for the first time, identified a biochemical signal in the blood associated with the faster-progressing form of Parkinson’s. Such a biomarker could help doctors predict early on, just after the onset of motor symptoms, how rapidly the disease will progress.

Hey, check out all the engineering jobs. Post your resume today!

MORE ON THIS TOPIC